{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:34:33Z","timestamp":1790832873232,"version":"4.1.0"},"reference-count":59,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1120,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1998,12]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Primary aldosteronism (PA) is the most common endocrine cause of curable hypertension, but no single test unequivocally identifies it. Accordingly, we investigated the usefulness of a logistic multivariate discriminant analysis (MDA) approach for PA screening.<\/jats:p><\/jats:sec><jats:sec><jats:title>DESIGN<\/jats:title><jats:p>Generation of a logistic MDA function based on retrospective analysis of biochemical tests in a large cohort of referred patients with\/without confirmed Conn's adenoma (CA), followed by prospective validation of the model.<\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS<\/jats:title><jats:p>We investigated 574 selected hypertensives: 206 (32 with and 174 without CA) retrospectively, 48 (with a 13% prevalence of CA) prospectively for the validation of the model, and 320 referred hypertensives (with a 3.4% prevalence of CA) similarly evaluated. Patients were referred to a specialised centre for hypertension (4th Clinica Medica\u2014University of Padua) and to a department of Internal Medicine of a regional hospital (Reggio Emilia).<\/jats:p><\/jats:sec><jats:sec><jats:title>MEASUREMENTS<\/jats:title><jats:p>In all patients we measured several demographic and biochemical variables and performed a captopril test. A stepwise analysis of variance, based on a model fitted with several different variables, identified baseline (sALDO) and captopril\u2010suppressed plasma aldosterone (cALDO), supine plasma renin activity (sPRA) and K<jats:sup>+<\/jats:sup> as the most informative. Therefore, two models of logistic MDA with sPRA, K<jats:sup>+<\/jats:sup>, and either sALDO (model A) or cALDO (model B) were developed and used. ROC analysis was also performed to assess the optimal cut\u2010off values.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>The model B of MDA provided the best performance and identified CA with 100% sensitivity and 81% accuracy. When used prospectively it showed 100% sensitivity, both in the Padua (88% accuracy) and in the Reggio Emilia series (90% accuracy). However, at both institutions most patients with idiopathic hyperaldosteronism (IHA) were also detected.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Thus, although developed from patients with confirmed Conn's adenoma, a strategy based on multivariate discriminant analysis can be used prospectively for accurate screening for primary aldosteronism. Furthermore, it was proven to be accurate and applicable to patients tested with similar modalities at a different institution. Although this approach did not provide a clear\u2010cut discrimination of Conn's adenoma from idiopathic hyperaldosteronism, it may avoid unnecessary and costly further testing in patients with a low probability of primary aldosteronism.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2265.1998.00608.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:39:12Z","timestamp":1047379152000},"page":"713-723","source":"Crossref","is-referenced-by-count":67,"title":["Screening for primary aldosteronism with a logistic multivariate discriminant analysis<sup>*<\/sup>"],"prefix":"10.1111","volume":"49","author":[{"given":"Gian Paolo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermanno","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Pavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Rosati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Zecchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Semplicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Perazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille C.","family":"Pessina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(89)90164-7"},{"key":"e_1_2_6_3_2","unstructured":"Biglieri E.G.&Irony I.(1990) Primary aldosteronism. InEndocrine hypertension. (eds. E.G. Biglieri & J.C. Melby) pp.71\u201385. Raven Press Ltd. New York."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.184.3.1509036"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-11-199412010-00010"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.1986.11699456"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.60.5.379"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30097-5"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)91022-7"},{"key":"e_1_2_6_10_2","first-page":"I\u2010191","article-title":"Calcium channel blockade with Nifedipine in primary aldosteronism","volume":"8","author":"Bravo E.L.","year":"1986","journal-title":"Hypertension"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.11.2_Pt_2.I207"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/1.3.88S"},{"key":"e_1_2_6_13_2","unstructured":"Chambers J.M.&Hastie T.J.(1991)Statistical models in S. Wadsworth and Brooks\/Cole Advanced Books & Software Pacific Grove."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1965.03090030022005"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1966.03100010077019"},{"key":"e_1_2_6_16_2","unstructured":"Everitt B.S.&Dunn G.(1991) Discriminant analysis. InApplied multivariate data analysis. (eds B.S. Everitt & G. Dunn) pp.225\u2013237. Edward Arnold London UK."},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02067355"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(70)92811-4"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(78)90370-8"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/4.9.786"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.141.2.299"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35781-6"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03349761"},{"issue":"5","key":"e_1_2_6_24_2","first-page":"S103","article-title":"Angiotensin\u2010responsie aldosterone\u2010producing adenoma masquerades as idiopathic hyperaldosteronism (iha: adrenal hyperplasia) or low\u2010renin hypertension","volume":"5","author":"Gordon R.D.","year":"1987","journal-title":"Journal of Hypertension"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1991.tb01446.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1993.tb01687.x"},{"key":"e_1_2_6_27_2","unstructured":"Gordon R.D. Stowasser M. Klemm S.A.&Tunny T.J.(1994) Primary aldosteronism and other forms of mineralcorticoid hypertension. InTextbook of Hypertension(ed Swales J.D.) pp.865\u2013892. Blackwell Scientific Publications Oxford."},{"key":"e_1_2_6_28_2","first-page":"553","article-title":"Selection and interpretation of diagnostic tests and procedures","volume":"94","author":"Griner P.F.","year":"1981","journal-title":"Annals of Internal Medicine"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.1985.tb02641.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.143.1.7063747"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.148.3.6878708"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1981.00340130033011"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.6.5.717"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/3.7.576"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj1954.37.151"},{"key":"e_1_2_6_36_2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ajh\/6.11.899","article-title":"The usefulness of the captopril test as a simultaneous screening for primary aldosteronism and renovascular hypertension","volume":"6","author":"Iwaoka T.","year":"1993","journal-title":"American Journal of Hypertension"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-60-1-67"},{"key":"e_1_2_6_38_2","unstructured":"Kleinbaum D.G. Kupper L.L.&Muller K.E.(1988)Applied regression analysis and other multivariable methods. pp.560\u2013594. PWS\u2010Kent Publishing Company Boston USA."},{"key":"e_1_2_6_39_2","first-page":"564","article-title":"Plasma aldosterone\u2010plasma renin activity ratio. A simple test to identify patients with primary aldosteronism","volume":"113","author":"Lins P.E.","year":"1986","journal-title":"Acta Endocrinologica Copenhagen"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-5-892"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1042\/cs061289s"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1159\/000167213"},{"key":"e_1_2_6_43_2","doi-asserted-by":"crossref","unstructured":"Mc Cullagh P.&Nelder J.A.(1989)Generalized Linear Models. Chapman and Hall London.","DOI":"10.1007\/978-1-4899-3242-6"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.5.1.116"},{"key":"e_1_2_6_45_2","unstructured":"Michie D. Spiegelhalter D.J.&Taylor C.C.(1994)Machine learning neural and statistical classification. Ellis Horwood New York."},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-76-6-899"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(93)90121-C"},{"key":"e_1_2_6_48_2","first-page":"357","article-title":"Imaging of aldosterone\u2010secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism","volume":"7","author":"Rossi G.P.","year":"1993","journal-title":"Journal of Human Hypertension"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.17.105"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-1-199507010-00013"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199510000-00013"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.27.5.1039"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-76-6-391"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90786-1"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.4.873"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1996.tb02059.x"},{"key":"e_1_2_6_57_2","unstructured":"Vaughan E.D.J. Atlas S.&Carey R.M.(1989) Hyperaldosteronism. InAdrenal disorders(eds. E.D.J. Vaughan & R.M. Carey) pp.243\u2013258. Thieme Medical Publisher Inc. New York."},{"key":"e_1_2_6_58_2","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.1993.00410180075008","article-title":"The diagnosis of primary aldosteronism and separation of two major subtypes","volume":"153","author":"Weinberger M.H.","year":"1993","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-90-3-386"},{"key":"e_1_2_6_60_2","doi-asserted-by":"crossref","unstructured":"Young W.F.J. Hogan M.J. Klee G.G. Grant C.S.&Van Heerden J.A.(1990) Primary aldosteronism: diagnosis and treatment.Mayo Clinic Proceedings 65 96\u2013110.","DOI":"10.1016\/S0025-6196(12)62114-4"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00608.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.00608.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1998.00608.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T03:29:51Z","timestamp":1698463791000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1998.00608.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["10.1046\/j.1365-2265.1998.00608.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00608.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}